Reaction
Infusion Site Vesicles reporting signals
As of the last recalculation, Infusion Site Vesicles appears in 516 FAERS reports alongside 12 co-occurring drug terms. The strongest observed disproportionality signal is TREPROSTINIL (PRR 102.7).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Treprostinil | 198 | 102.7 | 102.8 |
| Ketoprofen | 17 | 54.0 | 54.1 |
| Amitriptyline Hydrochloride | 18 | 42.8 | 42.9 |
| Macitentan | 58 | 37.9 | 38.0 |
| Sildenafil | 48 | 36.7 | 36.8 |
| Riociguat | 27 | 35.2 | 35.2 |
| Tadalafil | 72 | 33.5 | 33.6 |
| Ambrisentan | 84 | 32.2 | 32.2 |
| Sildenafil Powder, | 26 | 31.0 | 31.0 |
| Sildenafil Citrate | 74 | 27.2 | 27.2 |
| Aprepitant | 12 | 26.8 | 26.8 |
| Selexipag | 15 | 24.1 | 24.1 |